KINTOR PHARMA-B: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023
KINTOR PHARMA-B: ANNUAL REPORT 2023
KINTOR PHARMA-B: DISCLOSABLE TRANSACTION - RETURN OF LAND USE RIGHT IN PINHU, ZHEJIANG, PRC
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF GT20029 FOR TREATMENT OF ANDROGENETIC ALOPECIA IN CHINA REACHED PRIMARY ENDPOINT
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
KINTOR PHARMA-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
KINTOR PHARMA-B: DATE OF BOARD MEETING
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
KINTOR PHARMA-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
KINTOR PHARMA-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL OF KX-826 AND MINOXIDIL COMBINATION THERAPY FOR THE TREATMENT OF MALE AGA RECEIVED CLEARANCE BY CHINA NMPA
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
KINTOR PHARMA-B: INSIDE INFORMATION RESULTS OF KX-826 PHASE III CLINICAL TRIAL FOR TREATMENT OF MALE AGA IN CHINA
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
KINTOR PHARMA-B: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2022 ANNUAL REPORT AND THE 2023 INTERIM REPORT
KINTOR PHARMA-B: Notification Letter to Non-registered holders - Notice of Publication of 2023 Interim Report and Request Form
No Data